Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia-Reference-Cited by-同舟云学术

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia

Published:2023-07 Issue:7 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Zhou Xinping¹²³⁴^ORCID,Lang Wei¹,Mei Chen¹²³⁴,Ren Yanling¹²³⁴,Ma Liya¹²³⁴,Jiang Lingxu¹,Ye Li¹²³⁴,Xu Gaixiang¹²³⁴,Luo Yingwan¹²³⁴,Liu Lixia⁵,Cao Shanbo⁵,Qin Jiayue⁵^ORCID,Tong Hongyan¹²³⁴

Affiliation:

1. Department of Hematology, The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

2. Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy Zhejiang University Hangzhou China

3. Zhejiang Provincial Clinical Research Center for Hematological disorders Hangzhou China

4. Zhejiang University Cancer Center Hangzhou China

5. Department of Medical Affairs Acornmed Biotechnology Co., Ltd. Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1349

Reference5 articles.

1. Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

2. Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML

3. Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

4. Using circulating tumor DNA to monitor myelodysplastic syndromes status

5. Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

3. Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy;Journal for ImmunoTherapy of Cancer;2024-03